Logo image of UONEK

URBAN ONE INC (UONEK) Stock Fundamental Analysis

NASDAQ:UONEK - Nasdaq - US91705J2042 - Common Stock - Currency: USD

0.679  +0.04 (+6.95%)

After market: 0.6451 -0.03 (-4.99%)

Fundamental Rating

3

Overall UONEK gets a fundamental rating of 3 out of 10. We evaluated UONEK against 97 industry peers in the Media industry. Both the profitability and the financial health of UONEK get a neutral evaluation. Nothing too spectacular is happening here. UONEK does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year UONEK has reported negative net income.
In the past year UONEK had a positive cash flow from operations.
In multiple years UONEK reported negative net income over the last 5 years.
In the past 5 years UONEK always reported a positive cash flow from operatings.
UONEK Yearly Net Income VS EBIT VS OCF VS FCFUONEK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M

1.2 Ratios

With a Return On Assets value of -13.99%, UONEK is not doing good in the industry: 75.26% of the companies in the same industry are doing better.
UONEK's Return On Equity of -78.27% is on the low side compared to the rest of the industry. UONEK is outperformed by 75.26% of its industry peers.
UONEK has a better Return On Invested Capital (7.08%) than 76.29% of its industry peers.
The Average Return On Invested Capital over the past 3 years for UONEK is in line with the industry average of 7.56%.
Industry RankSector Rank
ROA -13.99%
ROE -78.27%
ROIC 7.08%
ROA(3y)-2.73%
ROA(5y)-1.22%
ROE(3y)-16.58%
ROE(5y)-8.39%
ROIC(3y)7.75%
ROIC(5y)8.24%
UONEK Yearly ROA, ROE, ROICUONEK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 200

1.3 Margins

UONEK has a Operating Margin of 16.42%. This is amongst the best in the industry. UONEK outperforms 81.44% of its industry peers.
UONEK's Operating Margin has declined in the last couple of years.
The Gross Margin of UONEK (69.56%) is better than 85.57% of its industry peers.
In the last couple of years the Gross Margin of UONEK has remained more or less at the same level.
Industry RankSector Rank
OM 16.42%
PM (TTM) N/A
GM 69.56%
OM growth 3Y-14.33%
OM growth 5Y-9.91%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.4%
GM growth 5Y-0.17%
UONEK Yearly Profit, Operating, Gross MarginsUONEK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), UONEK is creating some value.
Compared to 1 year ago, UONEK has less shares outstanding
Compared to 5 years ago, UONEK has about the same amount of shares outstanding.
The debt/assets ratio for UONEK is higher compared to a year ago.
UONEK Yearly Shares OutstandingUONEK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
UONEK Yearly Total Debt VS Total AssetsUONEK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

Based on the Altman-Z score of -0.32, we must say that UONEK is in the distress zone and has some risk of bankruptcy.
UONEK has a Altman-Z score of -0.32. This is in the lower half of the industry: UONEK underperforms 72.16% of its industry peers.
UONEK has a debt to FCF ratio of 16.18. This is a negative value and a sign of low solvency as UONEK would need 16.18 years to pay back of all of its debts.
The Debt to FCF ratio of UONEK (16.18) is comparable to the rest of the industry.
UONEK has a Debt/Equity ratio of 3.46. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 3.46, UONEK is not doing good in the industry: 79.38% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 3.46
Debt/FCF 16.18
Altman-Z -0.32
ROIC/WACC1.07
WACC6.63%
UONEK Yearly LT Debt VS Equity VS FCFUONEK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 2.96 indicates that UONEK has no problem at all paying its short term obligations.
UONEK's Current ratio of 2.96 is amongst the best of the industry. UONEK outperforms 89.69% of its industry peers.
A Quick Ratio of 2.96 indicates that UONEK has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 2.96, UONEK belongs to the top of the industry, outperforming 89.69% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.96
Quick Ratio 2.96
UONEK Yearly Current Assets VS Current LiabilitesUONEK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

1

3. Growth

3.1 Past

The earnings per share for UONEK have decreased strongly by -1681.08% in the last year.
Looking at the last year, UONEK shows a decrease in Revenue. The Revenue has decreased by -7.36% in the last year.
The Revenue has been growing slightly by 0.58% on average over the past years.
EPS 1Y (TTM)-1681.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-276.08%
Revenue 1Y (TTM)-7.36%
Revenue growth 3Y0.7%
Revenue growth 5Y0.58%
Sales Q2Q%-11.66%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
UONEK Yearly Revenue VS EstimatesUONEK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for UONEK. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
UONEK Price Earnings VS Forward Price EarningsUONEK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

94.85% of the companies in the same industry are more expensive than UONEK, based on the Enterprise Value to EBITDA ratio.
UONEK's Price/Free Cash Flow ratio is rather cheap when compared to the industry. UONEK is cheaper than 98.97% of the companies in the same industry.
Industry RankSector Rank
P/FCF 0.91
EV/EBITDA 3.68
UONEK Per share dataUONEK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

UONEK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

URBAN ONE INC

NASDAQ:UONEK (7/3/2025, 8:14:58 PM)

After market: 0.6451 -0.03 (-4.99%)

0.679

+0.04 (+6.95%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)05-13 2025-05-13/bmo
Earnings (Next)08-06 2025-08-06
Inst Owners27.21%
Inst Owner Change-5.97%
Ins Owners53.77%
Ins Owner Change0%
Market Cap31.01M
Analysts84.44
Price TargetN/A
Short Float %0.21%
Short Ratio1.19
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.07
P/FCF 0.91
P/OCF 0.74
P/B 0.19
P/tB N/A
EV/EBITDA 3.68
EPS(TTM)-2.69
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.75
FCFY109.9%
OCF(TTM)0.92
OCFY135.57%
SpS9.58
BVpS3.49
TBVpS-8.75
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -13.99%
ROE -78.27%
ROCE 8.96%
ROIC 7.08%
ROICexc 8.27%
ROICexgc 44.54%
OM 16.42%
PM (TTM) N/A
GM 69.56%
FCFM 7.79%
ROA(3y)-2.73%
ROA(5y)-1.22%
ROE(3y)-16.58%
ROE(5y)-8.39%
ROIC(3y)7.75%
ROIC(5y)8.24%
ROICexc(3y)9.08%
ROICexc(5y)9.37%
ROICexgc(3y)50.06%
ROICexgc(5y)49.19%
ROCE(3y)9.81%
ROCE(5y)10.43%
ROICexcg growth 3Y10.77%
ROICexcg growth 5Y-3.67%
ROICexc growth 3Y0.32%
ROICexc growth 5Y-0.34%
OM growth 3Y-14.33%
OM growth 5Y-9.91%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.4%
GM growth 5Y-0.17%
F-Score5
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 3.46
Debt/FCF 16.18
Debt/EBITDA 4.34
Cap/Depr 14.41%
Cap/Sales 1.82%
Interest Coverage 1.58
Cash Conversion 33.08%
Profit Quality N/A
Current Ratio 2.96
Quick Ratio 2.96
Altman-Z -0.32
F-Score5
WACC6.63%
ROIC/WACC1.07
Cap/Depr(3y)11.58%
Cap/Depr(5y)10.7%
Cap/Sales(3y)1.54%
Cap/Sales(5y)1.41%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1681.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-276.08%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-7.36%
Revenue growth 3Y0.7%
Revenue growth 5Y0.58%
Sales Q2Q%-11.66%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-16.25%
EBIT growth 3Y-13.72%
EBIT growth 5Y-9.39%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-44.58%
FCF growth 3Y-25.75%
FCF growth 5Y-10.74%
OCF growth 1Y-38.81%
OCF growth 3Y-22.4%
OCF growth 5Y-8.52%